MC2 Therapeutics A/S: Financial statements 2024
CVR: 29526346
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 24,493,422 and a net result of DKK -53,006,931 compared with DKK -41,851,166 the year before. That is a decrease of 7.1% compared with the year before. Equity in the 2024 report amounted to DKK -218,391,018. The company had 16 employees in the financial year.
- Gross Profit
- DKK 24,493,422
- Profit/Loss
- DKK -53,006,931
- Equity
- DKK -218,391,018
- Total Assets
- DKK 64,386,327
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 24.5M | -53M | -218.4M | 16 |
| 2023 | - | 26.4M | -41.9M | -164.5M | 29 |
| 2022 | - | 25M | -101.3M | -122.6M | 30 |
| 2021 | - | 27.7M | -25.2M | -21.1M | 19 |
| 2020 | - | 15.9M | -86.9M | 13.9M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MC2 Therapeutics A/S has published its annual report for 2023. Gross profit came to DKK 26,355,182, and the net result was DKK -41,851,166.
About MC2 Therapeutics A/S
MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.